Search
Menu
Home
HTB
2018
January
22
22 January 2018
Contents
Editorial
22 January 2018: vol 19 no 2
Special reports
HIV in the UK 2017: a shift to eliminate AIDS
Antiretrovirals
Doravirine FDC submitted to FDA in US: decision expected October 2018
Guidelines
UK guidelines on TB/HIV co-infection: online for comment to 9 February (2018)
US HIV guidelines updated (October 2017): dropping “HIV-infected”
HIV prevention and transmission
Update on PrEP IMPACT study – January 2018
PrEP use can reduce HIV stigma in gay communities
European HIV/AIDS surveillance report published (2017)
Cure-related research
Additional remission cases published: but eradication needs 10,000-fold reduction in viral reservoir
HIV vaccine update: the “Miami macaque” as proof-of-concept breakthrough?
On the web
Liverpool University PK online videos
Future meetings
Future meetings 2018
PDFs
22 January 2018 – vol 19 no 2
HTB RSS
Early access
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines
30 June 2025
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
28 June 2025
Clinical studies of two once-weekly pipeline compounds put on hold
27 June 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Why the new HIV PrEP guidelines from the UK are so exciting
2 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate